Publications dans lesquelles il/elle collabore avec Juan Cabezas Herrera (24)

2023

  1. Targeting protein methylation in pancreatic cancer cells results in KRAS signaling imbalance and inhibition of autophagy

    Cell Death and Disease, Vol. 14, Núm. 11

2021

  1. Acriflavine, a potent inhibitor of HIF-1α, disturbs glucose metabolism and suppresses ATF4-protective pathways in melanoma under non-hypoxic conditions

    Cancers, Vol. 13, Núm. 1, pp. 1-17

  2. MITF induces escape from innate immunity in melanoma

    Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1

2020

  1. PRMT1-dependent methylation of BRCA1 contributes to the epigenetic defense of breast cancer cells against ionizing radiation

    Scientific Reports, Vol. 10, Núm. 1

2017

  1. Lipid rafts of mouse liver contain nonextended and extended acetylcholinesterase variants along with M3 muscarinic receptors

    FASEB Journal, Vol. 31, Núm. 2, pp. 544-555

2016

  1. Cholinergic system and cell proliferation

    Chemico-Biological Interactions, Vol. 259, pp. 257-265

  2. Targeting the epigenetics of the DNA damage response in breast cancer

    Cell Death and Disease, Vol. 7

  3. Tumor suppressor SET9 guides the epigenetic plasticity of breast cancer cells and serves as an early-stage biomarker for predicting metastasis

    Oncogene, Vol. 35, Núm. 47, pp. 6143-6152

2015

  1. Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma

    BMC Cancer, Vol. 15, Núm. 1

  2. Targeting the epigenetic machinery of cancer cells

    Oncogene, Vol. 34, Núm. 2, pp. 135-143

2014

  1. Most acetylcholinesterase activity of non-nervous tissues and cells arises from the AChE-H transcript

    Journal of Molecular Neuroscience, Vol. 53, Núm. 3, pp. 429-435

2013

  1. Directed Phenotype Switching as an Effective Antimelanoma Strategy

    Cancer Cell, Vol. 24, Núm. 1, pp. 105-119

  2. Suppression of antifolate resistance by targeting the myosin Va trafficking pathway in melanoma

    Neoplasia (United States), Vol. 15, Núm. 7, pp. 826-839

  3. The AChE membrane-binding tail PRiMA is down-regulated in muscle and nerve of mice with muscular dystrophy by merosin deficiency

    Chemico-Biological Interactions

2012

  1. Changes in the expression and structure of cholinesterases in excitable and non-excitable tissues of the merosin-deficient Lama2dy mouse, a model of congenital muscular dystrophy

    Cholinesterase: Production, Uses and Health Effects (Nova Science Publishers, Inc.), pp. 1-32

  2. Melanoma coordinates general and cell-specific mechanisms to promote methotrexate resistance

    Experimental Cell Research, Vol. 318, Núm. 10, pp. 1146-1159

  3. Reactivation of the Tumour Suppressor RASSF1A in Breast Cancer by Simultaneous Targeting of DNA and E2F1 Methylation

    PLoS ONE, Vol. 7, Núm. 12

2011

  1. Comparison of a Pair of Synthetic Tea-Catechin-Derived Epimers: Synthesis, Antifolate Activity, and Tyrosinase-Mediated Activation in Melanoma

    ChemMedChem, Vol. 6, Núm. 3, pp. 440-449

2010

  1. Expression of cholinesterases in human kidney and its variation in renal cell carcinoma types

    FEBS Journal, Vol. 277, Núm. 21, pp. 4519-4529

  2. Mechanism of dihydrofolate reductase downregulation in melanoma by 3-O-(3,4,5-trimethoxybenzoyl)-(-)-epicatechin

    Journal of Cellular Biochemistry, Vol. 110, Núm. 6, pp. 1399-1409